Thank you, Mark, and good morning, everyone. Our Q3 net investment income benefited from a diverse combination of coupon income, transaction fees and yield-enhancing provisions such as MOICs and prepayment premiums. We remain highly selective with new investments as we were effectively at full investment during most of the quarter as we successfully achieved our targeted leverage level of 1.25 times. In addition, we have been passing on a historically higher percentage of potential investments based on credit and pricing considerations. As Mark discussed in his remarks, market conditions remain competitive as capital inflows continue to chase transactions, resulting in lower coupon spreads, higher leverage attachment levels and easing credit terms throughout the leverage loan markets. We continue to strategically focus on first-line investing at the top of the capital structure and prefer to utilize secured yield-enhancing provisions such as PIK features, call protection, make whole provisions and MOICs to incrementally enhance yields at the top of the capital structure rather than reaching deeper into capital structures for mezzanine and equity co-investments. We believe our continued investment selectivity and proportional deployment levels relative to our fund size helped us to invest in first-line loans at higher spreads when compared to the overall loan markets during the quarter. The weighted average coupon for our total funded first-line debt investments for the quarter was the equivalent of SOFR plus 6%. We also continued our highly selective focus on secondary investments where we see attractive risk-return profiles or the opportunity to acquire lightly syndicated first-line loan tranches at significant discounts to par due to technical reasons where we expect to have active roles in the processes that drive the refinancing or restructuring of the investments. Historically, we’ve been able to realize healthy recoveries on our first-line restructured reorganized transactions as our realized weighted average total recoveries have been in excess of the advertised cost of those investments at the time of the restructuring. During the quarter, we successfully exited our restructured first-mean term loan investment in Heritage Power that we acquired at approximately 58% of par value. We ultimately achieved an unlevered total cash return of approximately 1.4 times our gross investment cost over a three-year period and exited with a significant realized gain of several million dollars. The majority of our annual PIK income is strategically derived from highly structured situations such as our litigation finance investments where we can attain higher yields by matching flexible PIK timing features with strict cash flow sweeps upon collections or through coupon structures where PIK is incremental to our cash interest. Over 60% of our PIK investments are in portfolio companies risk rated either 1 or 2 and 95.4% risk rated 3 or better. As a result, we believe this PIK income may not compare to restructured PIK driven by a deterioration in credit. During the quarter, we received significant par paydowns within our litigation finance investments. We expect that trend to continue over the next several quarters. Litigation finance investments now comprise approximately 17% of our PIK income. Turning now to our Q3 investment and portfolio activity, our third quarter pipeline consisted of add-on and refinancing investment opportunities for our portfolio companies, as well as a new platform acquisition transaction. We completed a new private direct first-lien financing for Ascension Property Services where we served as co-lead arranger. We additionally completed add-on investments for portfolio companies including David’s Bridal, STATinMED, Community Tree Service, K&N, American Clinical Services, and Stengel Architecture. We also completed first-lien re-financings for portfolio companies including Senex and Avison Young and an incremental secondary equity investment in Longview Power. During Q3, we made a total of $97 million in investment commitments across one new and 10 existing portfolio companies of which $78 million was funded. Approximately 23% were direct first-lien loans to new portfolio companies, 76% primary first-lien loans to existing portfolio companies and 1% for equity investments in existing portfolio companies. We also funded a total of $15 million of previously unfunded commitments. We had sales and repayments totaling $154 million for the quarter which consisted of the full pay down of investment tranches in WIS, Global Telink, Homer City, New Cycle, USALCO, and Fluid Control, the refinancing of our first lien investments in Senex and Avison Young, and the sale of our investments in Powers Presents and Heritage Power. Approximately $49 million or nearly 40% of our total repayments for the quarter occurred on the last day of the quarter. We expect to redeploy these proceeds into our active Q4 pipeline. As a result of all these activities, our net funded investments decreased by approximately $61 million during the quarter. In terms of portfolio performance, our net asset value per share decreased from $16.08 per share in Q2 to $15.73 per share in Q3 driven primarily by unrealized net mark declines of approximately $22 million which represents approximately 1% of our total $1.8 billion portfolio. Approximately 75% of our net portfolio decline was driven by declines in the unrealized value of our equity investments, of which 90% related to our equity investments in David’s Bridal. As we mentioned on previous quarterly calls, we expect to see significant quarter-to-quarter volatility in the marks of David’s Bridal’s equity due to the larger overall relative size of our investment, as well as the highly seasonal nature of the company’s operations and working capital profile. Of note, we also saw declines in the unrealized mark value of our equity investments in TMK TriMark and Healthway. TriMark’s revenue demand from its diversified restaurant base is still experiencing the lingering macro effects of higher inflation and interest rates. In terms of unrealized mark gains, we had mark increases in the unrealized value of our debt investments in IWCO and Homer City Generation, as well as our equity investments in Carestream Health, our CION EagleTree joint venture, Longview Power, and Burl Lips, all of which were driven by stronger underlying performance trends. From a portfolio credit perspective, our non-accruals increased from 1.4% of fair value in Q2 to 1.8% in Q3. We added one name to the non-accrual this quarter, our term loan investment in STATinMED. CION led a super senior financing for STATinMED in partnership with the company’s private equity sponsor to help fund the growth of its new subscription-based offering to the pharmaceutical industry, which we expect to grow rapidly. The terms of the priority super senior round are initially dilutive to the STATinMED term loan mark valuation, which is the primary driver of our decision to place on non-accrual for now. There are several names, including STATinMED, that we continue to reevaluate for potential return to accrual status based on financial performance, transaction related and other positive developments. On an absolute basis, non-accruals continue to be largely in line with historical experience and we are pleased with the continued credit performance of our portfolio, particularly in the current interest rate environment. Overall, our portfolio remains defensive in nature with 85% in first-lien investments. Approximately 98% of our portfolio remains risk rated 3 or better. Our risk rated 3 investments, which are investments where we expect full repayment, but are either spending more engagement time and/or have seen the increased risk since the initial asset purchase increased from approximately 9.1% of the portfolio in Q2 to 11.8% in Q3, driven primarily by our investments in Hollander and TriMark. I will now turn the call over to Keith.